Related Experiment Video
Updated: Jun 25, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Immune surveillance and immunotherapy: lessons from carbohydrate mimotopes
Anastas Pashov1, Behjatolah Monzavi-Karbassi, Thomas Kieber-Emmons
1Department of Pathology and Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, United States of America.
Abstract:
The immune system plays an intricate role in tumorigenesis, therefore cancer immunotherapy borrows concepts both from autoimmunity and vaccinology. Due to tumor-induced immune suppression, the adjuvant setting seems most suitable for immunotherapy, which optimally targets multiple tumor associated antigens after removal of the bulk of the tumor. The responses elicited need not match the intensity of those against pathogens. Retrospective studies suggest that cancer patients' survival correlates with low-titer anti-tumor IgM antibodies. Carbohydrate mimetic peptides (CMPs) prove instrumental as immunogens by boosting similar persistent IgM anti-tumor responses, engaging the innate/adaptive immunity interface and promoting cytotoxic responses and epitope spreading.
Related Concept Videos
Tumor Immunotherapy
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Cell-mediated Immune Responses
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

